Have your own idea? Try our Stock Screener
Belgian (BEL20) Healthcare Sector Analysis
UpdatedMay 03, 2026
DataAggregated Company Financials
Companies11
- 7D-1.8%
- 3M-7.5%
- 1Y26.5%
- YTD-4.7%
Over the last 7 days, the Healthcare industry has dropped 1.8%, driven by UCB declining 3.3%. This takes the industry's 12 month performance to a gain of 26%. As for the next few years, earnings are expected to grow by 20% per annum.
Sector Valuation and Performance
Has the Belgian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 03 May 2026 | €97.0b | €14.1b | €2.7b | 28.2x | 36.5x | 6.9x |
| Tue, 31 Mar 2026 | €98.0b | €14.2b | €2.7b | 30.1x | 36.7x | 6.9x |
| Thu, 26 Feb 2026 | €108.0b | €12.7b | €2.6b | 29.7x | 41.1x | 8.5x |
| Sat, 24 Jan 2026 | €104.5b | €12.7b | €2.6b | 29.8x | 39.8x | 8.3x |
| Mon, 22 Dec 2025 | €103.0b | €12.7b | €2.6b | 27.8x | 39.1x | 8.1x |
| Wed, 19 Nov 2025 | €102.9b | €12.7b | €2.7b | 25x | 38.8x | 8.1x |
| Fri, 17 Oct 2025 | €105.2b | €12.2b | €2.4b | 28.2x | 43.3x | 8.6x |
| Sun, 14 Sep 2025 | €89.0b | €12.2b | €2.4b | 32.8x | 36.7x | 7.3x |
| Tue, 12 Aug 2025 | €78.8b | €12.1b | €2.4b | 33.4x | 32.7x | 6.5x |
| Thu, 10 Jul 2025 | €69.6b | €11.0b | €1.9b | 33.5x | 35.9x | 6.3x |
| Sat, 07 Jun 2025 | €71.0b | €11.0b | €2.0b | 35.1x | 36.1x | 6.4x |
| Mon, 05 May 2025 | €75.8b | €10.7b | €1.8b | 35.8x | 42.5x | 7.1x |
| Wed, 02 Apr 2025 | €72.3b | €10.8b | €1.9b | 41.3x | 39.1x | 6.7x |
| Fri, 28 Feb 2025 | €80.1b | €10.8b | €1.9b | 46.4x | 41.4x | 7.4x |
| Sun, 26 Jan 2025 | €82.8b | €9.7b | €270.4m | 62.7x | 306.3x | 8.5x |
| Tue, 24 Dec 2024 | €80.8b | €9.8b | €270.0m | 59.9x | 299.4x | 8.3x |
| Thu, 21 Nov 2024 | €73.7b | €9.7b | €270.5m | 56.7x | 272.5x | 7.6x |
| Sat, 19 Oct 2024 | €72.1b | €9.5b | €130.7m | 61.6x | 551.7x | 7.6x |
| Mon, 16 Sep 2024 | €68.3b | €9.4b | €133.0m | 57.6x | 514x | 7.3x |
| Wed, 14 Aug 2024 | €65.9b | €9.4b | €60.8m | 56.9x | 1084.5x | 7x |
| Fri, 12 Jul 2024 | €60.7b | €8.9b | €38.6m | 55.9x | 1571.9x | 6.8x |
| Sun, 09 Jun 2024 | €53.2b | €8.9b | €36.7m | 52.9x | 1450.9x | 6x |
| Tue, 07 May 2024 | €51.1b | €8.7b | €61.1m | 47.6x | 836.8x | 5.8x |
| Thu, 04 Apr 2024 | €50.3b | €8.7b | €40.7m | 45.3x | 1235x | 5.8x |
| Sat, 02 Mar 2024 | €48.4b | €9.4b | -€127,680,020.40 | 45.4x | -379.3x | 5.2x |
| Mon, 29 Jan 2024 | €43.4b | €9.1b | -€126,523,109.00 | 39.7x | -342.7x | 4.7x |
| Wed, 27 Dec 2023 | €40.3b | €9.1b | -€123,498,098.00 | 37.6x | -326.2x | 4.4x |
| Fri, 24 Nov 2023 | €45.9b | €9.1b | -€121,776,656.00 | 33.1x | -376.6x | 5x |
| Sun, 22 Oct 2023 | €45.5b | €9.0b | -€302,630,135.00 | 33.3x | -150.5x | 5.1x |
| Tue, 19 Sep 2023 | €50.1b | €9.0b | -€359,968,208.00 | 35.1x | -139.2x | 5.5x |
| Thu, 17 Aug 2023 | €48.4b | €9.0b | -€339,995,069.00 | 41x | -142.3x | 5.4x |
| Sat, 15 Jul 2023 | €39.7b | €9.1b | -€335,569,292.00 | 36.4x | -118.2x | 4.4x |
| Mon, 12 Jun 2023 | €43.0b | €9.1b | -€358,366,781.00 | 39.3x | -119.9x | 4.7x |
| Wed, 10 May 2023 | €42.7b | €9.1b | -€334,394,946.00 | 38.8x | -127.8x | 4.7x |
Price to Earnings Ratio
-127.8x
Current Industry PE
- Investors are pessimistic on the Belgian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 36.5x which is lower than its 3-year average PE of 208x.
- The industry is trading close to its 3-year average PS ratio of 6.6x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 16% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare sector?
| BE Market | 0.87% | |
| Healthcare | -1.79% | |
| Healthcare Services | 1.69% | |
| Biotech | 0.27% | |
| Life Sciences | 0% | 0 |
| Healthtech | -0.63% | |
| Pharma | -3.43% | |
| Medical Equipment | -4.34% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 21.6%, which is lower than the prior year's growth of 146.0% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 83% over the next 5 years.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARGX argenx | €668.00 | 0.3% +€111.9m | 16.1% | PE37.7x | |
| FAGR Fagron | €24.00 | 1.7% +€29.3m | 13.7% | PE19.3x | |
| SEQUA Sequana Medical | €0.61 | 9.5% +€3.8m | -38.9% | PE-0.8x | |
| ALEMS European Medical Solutions | €5.25 | 7.1% +€1.5m | 7.1% | PE12.1x |
